Wellbeing Digital Sciences Inc. (NEO: MEDI) OTC: KONEF | FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that its subsidiary Mindscape Ketamine & Infusion Therapy, PLLC, has treated its 1,000th patient with IV Ketamine Therapy for treatment-resistant mood…